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Six ternary a-amino acid copper(II) complexes of the general formula [Cu(AA)(B)(H2O)](X) (1–6), where AA is L-leu = L-leucine (1–
3) or L-ile = L-isoleucine (4–6), B is a N,N-donor heterocyclic base, viz. 2,20-bipyridine (bpy, 1, 4), 1,10-phenanthroline (phen, 2, 5) and
dipyrido[3,2:20,30-f]quinoxaline (dpq, 3, 6) and X ¼ ClO4=NO3 have been synthesized, characterized, and their DNA binding and
cleavage activity studied. The bpy and dpq complexes of L-ile (4,6) have been structurally characterized by X-ray crystallography.
The complexes show a distorted square-pyramidal (4 + 1) CuN3O2 coordination geometry. The one-electron paramagnetic complexes
display a d–d band near 600 nm in water and show a cyclic voltammetric response due to a Cu(II)/Cu(I) couple near 0.1 V (vs.
SCE) in DMF-0.1 M TBAP. All complexes are 1:1 electrolytes. Binding interactions of the complexes with calf thymus DNA (CT-
DNA) have been investigated by absorption, emission, viscosity and DNA melting studies. The phen and dpq complexes are avid binders
to the calf thymus DNA, giving an order: (3,6) (dpq) > (2,5) (phen) (1,4) (bpy). The bpy complexes do not show any apparent binding
to the DNA and hence show poor DNA cleavage activity. The phen and dpq complexes (2,3,5,6) show eﬃcient oxidative cleavage of
pUC19 supercoiled DNA (SC-DNA) in the presence of the reducing agent 3-mercaptopropionic acid (MPA) involving hydroxyl radical
(OH) species, as evidenced from the control data showing inhibition of DNA cleavage in the presence of OH radical quenchers, viz.
DMSO, mannitol, KI and catalase.
 2008 Elsevier Ltd. All rights reserved.
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The development of compounds cleaving DNA under
physiological conditions, i.e. ‘artiﬁcial nucleases’, are of
current interest for their potential applications in genomic
research and as footprinting and therapeutic agents [1–10].
The ability to accomplish site-speciﬁc DNA cleavage will
undoubtedly allow the development of new chemothera-
peutic agents and antimicrobial drugs. In addition, artiﬁ-
cial nucleases will provide important new tools for DNA
manipulation to molecular biologists. For example, bis-0277-5387/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.poly.2007.12.026
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E-mail address: pr.chetana@gmail.com (P.R. Chetana).phenanthroline copper(I) complex is used in DNA-foot-
printing experiments [1], which are important for the
detailed study of DNA–protein interactions [7a]. 3d transi-
tion metal complexes are well suited for application as arti-
ﬁcial nucleases, because of their cationic nature, diverse
three-dimensional structural features depending on the
ligand systems, and the possibility to tune their redox
potential through the choice of proper ligands. The interac-
tion of transition metals like Mn, Fe and Cu, with dioxygen
in the presence of a reducing agent generates reactive oxy-
gen species (ROS) that ultimately may cleave DNA [7b].
The DNA cleavage could occur by two major pathways,
viz. hydrolytic and oxidative pathway. Hydrolytic DNA
cleavage involves cleavage of the phosphodiester bond to
Scheme 1. Complexes 1–6 and the heterocyclic bases.
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Zn(II), being a strong Lewis acid, exchanges ligands very
rapidly. Several Zn(II) complexes are well-known for their
hydrolase activity [7c]. Hydrolytic cleavage active species
mimic restriction enzymes. The oxidative DNA cleavage
involves either oxidation of the deoxyribose moiety by
abstraction of sugar hydrogen or oxidation of nucleobases.
Oxidative DNA cleavage by redox-active metal complexes,
like [Fe(edta)]2 or Cu(1,10-phenanthroline)2Cl2, is medi-
ated by the production of reactive oxygen species, like
HO, through a Fenton-type mechanism [10]. These free
radicals abstract the most accessible and exposed sugar
hydrogens and initiate the oxidative cleavage, leading to
DNA-cleavage products. The purine base guanine is most
susceptible for oxidation among the four nucleobases.
The role of ternary copper(II) complexes in biological sys-
tems is well known [11]. Among the transition metal based
DNA cleaving agents, copper phenanthroline complexes
are particularly primarily sugar directed. They are respon-
sible for direct strand scission by hydrogen atom abstrac-
tion from the deoxyribose moiety. Sigman and coworkers
have reported that the bis-(1,10-phenanthroline)copper(I)
complex in the presence of H2O2 act as a ‘chemical nucle-
ase’ that eﬃciently nicks DNA [1,2]. Recently there have
been several reports of copper(II) complexes showing eﬃ-
cient chemical nuclease activity [12–17]. Recent reports
have shown that amino acid/peptide based copper(II) com-
plexes show eﬃcient DNA cleavage activity by oxidative
and hydrolytic pathways [17–22]. Such complexes may
show DNA cleavage both in the presence (chemical nucle-
ase) or absence (hydrolytic) of a reducing agent. The
favored pathway depends on several factors, viz. Lewis
acidity, accessible redox potential and rate of ligand
exchange.
The present work stems from our interest to explore the
structural and functional properties of redox active ternary
copper(II) complexes having bioessential a-amino acids L-
leucine or L-isoleucine and N,N-donor heterocyclic bases
as a DNA groove binder. The eﬃciency of the DNA strand
scission can be enhanced by increasing the binding aﬃnity
of the metal complex for DNA. Typically such coordina-
tion complexes contain a DNA-binding moiety that binds
either at a groove, or act as an intercalator, thereby
increasing the DNA-targeting ability of the metal complex.
Our choice of 2,20-bipyridine (bpy), 1,10-phenanthroline
(phen) and dipyridoquinoxaline (dpq) are based on their
diﬀerences in DNA binding ability. Both L-leucine and L-
isoleucine are essential for development of skeletal muscle
tissue and preserve muscle glycogen levels [24].
Herein, we report the syntheses, structure, DNA binding
and oxidative DNA cleavage properties of ternary
copper(II) complexes of the general formula [Cu(L-leu/ile)
(B)(H2O)](X) (1–6) where B is a N,N-donor heterocyclic
base, viz. 2,20 -bipyridine (bpy,1,4); 1,10-phenanthroline
(phen,2,5) and dipyrido[3,2-d:20,30-f]quinoxaline (dpq, 3,
6), L-leu = L-leucine and L-ile = L-isoleucine (Scheme 1).
The bpy and dpq complexes of L-ile (4,6) have been struc-turally characterized by X-ray crystallography. Studies
have been made to explore the role of DNA binder and
amino acid along with mechanistic pathways involved in
the ‘chemical nuclease’ activity.
2. Experimental
2.1. Materials
All products were obtained from commercial sources
and were used without further puriﬁcation. Solvents used
for electrochemical and spectroscopic studies were puriﬁed
by standard procedures [25]. The supercoiled pUC19 DNA
(CsCl puriﬁed) was purchased from Bangalore Genei
(India). Calf thymus (CT) DNA, agarose (molecular biol-
ogy grade), distamycin-A, catalase, superoxide dismutase
(SOD) and ethidium bromide (EB) were obtained from
Sigma (USA). Tris(hydroxymethyl)aminomethane–HCl
(Tris–HCl) buﬀer solution was prepared by using deion-
ized, sonicated triple distilled water. The N,N-donor het-
erocyclic base dipyrido[3,2-d:20,30-f]quinoxaline (dpq) was
prepared by the literature procedure using 1,10-phenan-
throline-5,6-dione as a precursor and reacting it with ethy-
lenediamine [26]. The complexes 2 and 5 were prepared by
literature procedures [27].
2.2. Preparation of [Cu(AA)(B)(H2O)](X) (1–6)
(AA = L-leu (1–3) or L-ile (4–6); B = bpy, phen, dpq);
X ¼ NO3 (2,4,5); ClO4 (1,3,6)
The complexes were prepared by following a modiﬁed
reported [27] synthetic procedure in which a 10 ml aqueous
solution of Cu(NO3)2  3H2O (0.48 g) or Cu(ClO4)  6H2O
(0.75 g) (2.0 mmol) was reacted with L-leucine or L-isoleu-
cine (0.27 g, 2.1 mmol) treated with NaOH (0.08 g,
2.0 mmol) in water (10 ml) under magnetic stirring at room
temperature. Slow evaporation of the solution at room
temperature yielded a crystalline material. Crystals of com-
plexes 4 and 6 were suitable for X-ray diﬀraction studies.
After 30 min, a 20 ml methanolic solution of the heterocy-
clic base [bpy (0.28 g), phen (0.35 g), dpq (0.42 g)
(1.8 mmol)] was added to the solution and the resulting
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ing the solution to an ambient temperature, it was ﬁltered
and the ﬁltrate on slow concentration yielded a crystalline
solid of the product. The solid was isolated and washed
with cold aqueous methanol and ﬁnally dried over P4O10
(Yield: 75%). Anal. Calc. for C16H22CuN3O7Cl (1): C,
41.12; H, 4.74; N, 8.99. Found: C, 41.32; H, 4.88; N,
8.85%. kmax, nm (e, M
1 cm1) in water: 604 (50), 310
(12560), 300 (12700), 242 (10,020). FT-IR, cm1 (KBr
disc): 3486br, 3340br, 3092m, 2953m, 2873w, 1633s,
1606s, 1498m, 1474m, 1446m, 1385s, 1316m, 1250m,
1110vs (ClO4
), 1067s, 976m, 833m, 770s, 731m, 652w,
620m, 553m, 416m (s, strong; m, medium; w, weak; br,
broad; vs, very strong). KM (X
1 cm2 M1) in water at
25 C: 104. leﬀ (solid, 298 K): 1.78 lB. Anal. Calc. for
C18H22CuN4O6 (2): C, 47.61; H, 4.88; N, 12.34. Found:
C, 47.35; H, 4.47; N, 12.18%. kmax, nm (e, M
1 cm1) in
water: 610 (55), 293 (9,640), 272 (31380), 204 (43860).
FT-IR, cm1 (KBr disc): 3385br, 3219br, 2953m, 1634s,
1585s, 1520m, 1430s, 1384vs (NO3
), 1315s, 1154m,
1130w, 1109w, 1041m, 984m, 918w, 857s, 826m, 782m,
723s, 649m, 559m, 429m. KM (X
1 cm2 M1) in water at
25 C: 122. leﬀ (solid, 298 K): 1.74 lB. Anal. Calc. for
C20H22CuN5O7Cl (3): C, 44.20; H, 4.08; N, 12.89. Found:
C, 44.13; H, 4.03; N, 12.78%. kmax, nm (e, M
1 cm1) in
water: 608 (74), 293 (15000), 257 (47600), 208 (31540).
FT-IR, cm1 (KBr disc): 3499br, 3293br, 2957m, 1594s,
1531w, 1486s, 1470m, 1407s, 1386s, 1215m, 1114s, 1084vs
(ClO4
), 879w, 824m, 732s, 625s, 576m, 438m. KM
(X1 cm2 M1) in water at 25 C: 115. leﬀ (solid, 298 K):
1.76 lB. Anal. Calc. for C16H22CuN4O6 (4): C, 44.68; H,
5.16; N, 13.03. Found: C, 44.56; H, 5.20; N, 12.78%. kmax,
nm (e, M1 cm1) in water: 604 (55), 310 (13420), 300
(13620), 243 (10220). FT-IR, cm1 (KBr disc): 3500br,
3287br, 3026m, 2959m, 2875m, 1654s, 1601s, 1497m,
1479m, 1383vs (NO3
), 1255m, 1159s, 1134m, 1086m,
1063m, 1033m, 1019m, 989m, 897m, 825w, 806w, 774s,
731s, 662w, 584w, 417m. KM (X
1 cm2 M1) in water at
25 C: 138. Anal. Calc. for C18H22CuN4O6 (5): C, 47.61;
H, 4.88; N, 12.34. Found: C, 47.43; H, 4.53; N, 12.43%.
kmax, nm (e, M
1 cm1) in water: 611 (55), 293 (8320),
272 (27620), 204 (38660). FT-IR, cm1 (KBr disc):
3444br, 3252br, 3133m, 3056w, 2956m, 2874m, 1644s,
1586m, 1518m, 1432m, 1382vs (NO3
), 1332m, 1225w,
1158m, 1108w, 1007m, 873w, 856s, 825m, 781m, 737w,
723s, 648m, 567m, 489w, 429m. KM (X
1 cm2 M1) in
water at 25 C: 127. leﬀ (solid, 298 K): 1.80 lB. Anal. Calc.
for C20H22CuN5O7Cl (6): C, 44.20; H, 4.08; N, 12.89.
Found: C, 44.33; H, 4.05; N, 12.93%. kmax, nm (e, M
1
cm1) in water: 609 (80), 295 (14400), 257 (45840), 208
(26260). FT-IR, cm1 (KBr disc): 3433br, 3286br,
3086m, 2961m, 1637s, 1582m, 1532m, 1487s, 1460m,
1407s, 1387s, 1213m, 1087vs (ClO4
), 873m, 823m, 733s,
625s, 568m, 431m. KM (X
1 cm2 M1) in water at 25 C:
106. leﬀ (solid, 298 K): 1.77 lB.
Solubility and stability. The complexes showed high sol-
ubility in water, methanol, dimethylformamide (DMF) anddimethyl sulfoxide (DMSO) and are insoluble in hydrocar-
bons. They are stable in the solid and in solution phases.
Caution! Perchlorate salts are potentially explosive and
only small quantities were handled with care.
2.3. General methods
The elemental analysis was done using a Thermo Finn-
igan FLASH EA 1112 CHNS analyzer. The infrared and
electronic spectra were recorded on Perkin–Elmer Lambda
35 and Perkin–Elmer spectrum one 55 spectrophotometers,
respectively. DNA melting experiments were carried out on
a Varian Cary 300 Bio UV–Vis spectrophotometer
attached to a Cary Peltier temperature controller. Molar
conductivity measurements were done using a Control
Dynamics (India) conductivity meter. Electrochemical
measurements were made at 25 C on an EG&G PAR
model 253 VersaStat potentiostat/galvanostat with electro-
chemical analysis software 270 using a three electrode setup
consisting of a glassy carbon working, platinum wire aux-
iliary and a saturated calomel reference electrode (SCE) in
DMF containing 0.1 M TBAP. The electrochemical data
were uncorrected for junction potentials. Magnetic suscep-
tibility data at 298 K were obtained using Model 300
Lewis-coil-force magnetometer of George Associates Inc.
(Berkley, USA) make.
2.4. X-ray crystallographic procedures
Single crystals of [Cu(L-ile)(bpy)(H2O)](NO3)  H2O
(4  H2O) and [Cu(L-ile)(dpq)(H2O)](ClO4) (6) were ob-
tained by slow evaporation of an aqueous-methanolic solu-
tion of the complexes. A rectangular single crystal was
mounted on a glass ﬁber and used for data collection. All
geometric and intensity data were collected at 293 K using
an automated Bruker SMART APEX CCD diﬀractometer
equipped with a ﬁne focus 1.75 kW sealed tube Mo Ka X-
ray source (k = 0.71073 A˚), with increasing x (width of
0.3/frame) at a scan speed of 5 and 2 s/frame for com-
plexes 4 and 6, respectively. Intensity data, collected using
the x–2h scan mode, were corrected for Lorentz-polariza-
tion eﬀects and for absorption [28]. SMART software was
used for data acquisition and SAINT software for data
extraction [29]. Absorption corrections were made using
SADABS [30]. The structures were solved and reﬁned by the
full-matrix least-squares method using the SHELX system
of programs [31]. All non-hydrogen atoms were reﬁned
anisotropically. All hydrogen atoms attached to the hetero-
atoms were in their calculated positions and reﬁned using a
riding model. Perspective views of the complexes were
obtained by ORTEP [32].
2.5. DNA binding experiments
The UV absorbance at 260 and 280 nm of the CT-DNA
solution in 5 mM Tris–HCl buﬀer (pH 7.2) gave a ratio of
1.9, indicating the DNA was free of protein [33]. The
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intensity at 260 nm with a known e value (6600 M1 cm1)
[34]. Absorption titration measurements were done by
varying the concentration of CT DNA, keeping the metal
complex concentration constant in 5 mM Tris–HCl/5 mM
NaCl buﬀer (pH 7.2). Samples were kept for equilibrium
before recording each spectrum. The intrinsic binding con-
stant (Kb) for the interaction of the complexes with CT-
DNA were determined from a plot of [DNA]/(ea  ef) vs.
[DNA] using absorption spectral titration data and the fol-
lowing equation:
½DNA=ðea  efÞ ¼ ½DNA=ðeb  efÞ þ ½Kbðeb  efÞ1;
where [DNA] is the concentration of DNA in base pairs.
The apparent absorption coeﬃcients ea, ef and eb corre-
spond to Aobsd./[Cu], the extinction coeﬃcient for the free
copper(II) complex and extinction coeﬃcient for the cop-
per(II) complex in the fully bound form, respectively [35].
Kb is given by the ratio of the slope to the intercept.
The apparent binding constant (Kapp) values of the com-
plexes were determined by a ﬂuorescence spectral technique
using ethidium bromide (EB) bound CT DNA solution in
Tris–HCl/NaCl buﬀer (pH, 7.2). The emission intensities
of EB at 600 nm (546 nm excitation) with an increasing
amount of the ternary complex concentration were
recorded. Ethidium bromide was non-emissive in Tris–buf-
fer medium due to ﬂuorescence quenching of the free EB by
the solvent molecules [36]. In the presence of DNA, EB
showed enhanced emission intensity due to its intercalative
binding to DNA. A competitive binding of the copper
complexes to CT DNA could result in the displacement
of EB or quenching of the bound EB by the paramagnetic
copper(II) species, decreasing its emission intensity.
DNA-melting experiments were carried out by monitor-
ing the absorbance ofCT-DNA (200 lMNP)at 260 nmwith
varying temperature in the absence and presence of the com-
plexes in a 2:1 ratio of DNA to complex with a ramp rate of
0.5 C min1 in phosphate buﬀer (pH 6.85) using a Peltier
system attached to the UV–Vis spectrophotometer.
Viscometric titrations were performed with a Schott
Gerate AVS 310 Automated Viscometer. The viscometer
was thermostated at 37 C in a constant temperature bath.
The concentration of DNA was 200 lM in NP and the ﬂow
times were measured with an automated timer, each sample
was measured three times and an average ﬂow time was
calculated. Data were presented as (g/g0)
1/3 vs. [complex]/
[DNA], where g is the viscosity of DNA in the presence
of complex and g0 was the viscosity of DNA alone. Viscos-
ity values were calculated from the observed ﬂowing time
of DNA-containing solutions (t) corrected for that of buf-
fer alone (t0), g = (t  t0) [37].
2.6. DNA cleavage experiments
The extent of cleavage of supercoiled (SC) DNA in the
presence of the complex and reducing agent MPA was
determined by agarose gel electrophoresis. In a typicalreaction, supercoiled pUC19 DNA (0.2 lg), taken in
50 mM Tris–HCl buﬀer (pH 7.2) containing 50 mM NaCl,
was treated with the complex. The extent of cleavage was
measured from the intensities of the bands using the UVI-
TEC Gel Documentation System.
For mechanistic investigations, inhibition reactions were
carried out by adding the reagents prior to the addition of the
complex. The solutions were incubated for 1 h in a dark
chamber at 37 C, followed by addition to the loading buﬀer
containing 25%bromophenol blue, 0.25% xylene cyanol and
30% glycerol (2 lL), and the solution was ﬁnally loaded on
1.0% agarose gel containing 1.0 lg/ml ethidium bromide
(EB). Electrophoresis was carried out for 2 h at 60 V in
tris–acetate–EDTA (TAE) buﬀer. Bands were visualized
byUV light and photographed for analysis. Due corrections
were made to the observed intensities for the low level of NC
form present in the original sample of SC DNA and for the
low aﬃnity of EB binding to SC in comparison to nicked cir-
cular (NC) and linear forms ofDNA [38]. The concentration
of the complexes or the additivesmentioned corresponded to
the quantity of the sample in 2 lL stock solution prior to
dilution to the 20 lL ﬁnal volume by Tris–HCl buﬀer.
3. Results and discussion
3.1. Synthesis and general aspects
The ternary copper(II) complexes are prepared in high
yield from the reaction of Cu(NO3)2  3H2O or
Cu(ClO4)2  6H2O with L-leucine/L-isoleucine and hetero-
cyclic bases. The complexes are stable and soluble in water
and common polar organic solvents. They are character-
ized from the analytical and physicochemical data (Table
1). The complexes display an intense charge transfer (CT)
band in the range 200–310 nm, that can be attributed to
the p? p* transition of the coordinated N,N-donor het-
erocyclic base. The d–d band is observed at 600 nm in
aqueous medium and is in agreement with a square-pyra-
midal geometry (Fig. 1). The complexes are redox active
and display a cyclic voltammetric response near 0.1 V
vs. SCE in DMF-0.1 M TBAP. The redox process is assign-
able to the Cu(II)/Cu(I) couple. The complexes show 1:1
electrolytic behavior in solution.
3.2. Crystal structures
The bpy and dpq complexes of L-isoleucine (4  H2O, 6)
are structurally characterized using the single-crystal X-ray
diﬀraction technique. Selected crystallographic data are
summarized in Table 2. The ORTEP views of the complexes
are shown in Figs. 2 and 3. Selected bond distances and
angles are given in Table 3. The crystal structures of [Cu
(L-leu)(phen)(H2O)](NO3) (2) and [Cu(L-ile)(phen)(H2O)]
(NO3) (5) are known [27]. Both the complexes showdistorted
(4 + 1) square-pyramidal geometry, in which Cu2+ coordi-
nates with two nitrogen atoms of 1,10-phenanthroline, the
amino nitrogen atom and one carboxylate oxygen atom of
Table 1
Physicochemical data for the ternary copper(II) complexes 1–6
Complex 1 2 3 4 5 6
IRa: [m (NO3
=ClO4
)/cm1] 1110 (ClO4
) 1384 (NO3
) 1084 (ClO4
) 1383 (NO3
) 1382 (NO3
) 1087 (ClO4
)
d–d band: kmax/nm (e/M
1 cm1)b 604 (50) 610 (55) 608 (74) 604 (55) 611 (55) 609 (80)
CV: E1/2/V (DEp/mV)
c 0.13 (430) 0.10 (330) 0.06 (390) 0.13 (440) 0.12 (340) 0.10 (360)
KM
d (X1 cm2 M1) 104 122 115 138 127 106
Ka
e (M1) 1.06  104 4.66  105 1.15  106 1.66  104 5.75  105 9.8  105
Kb
f (M1) 5.1  103 1.05  104 2.24  103 1.92  104
DTm
g (C) 1.0 (±0.2) 2.4 (±0.2) 3.2 (±0.2) 1.3 (±0.3) 2.7 (±0.2) 3.0 (±0.3)
a KBr phase.
b In aqueous medium.
c Cu(II)/Cu(I) couple in DMF–0.1 M TBAP. E1/2 = 0.5(Epa + Epc), DEp = |Epa  Epc|, where Epa and Epc are the anodic and cathodic peak potentials,
respectively. Scan rate: 50 mV s1.
d In aqueous medium at 25 C.
e Apparent DNA binding constant from competitive binding assay by the emission method.
f Intrinsic DNA binding constant (Kb) from the absorption spectral method.
g Changes in melting temperature of CT DNA.
Fig. 1. Electronic spectra of complexes 1 (—), 2 (  ) and 3 (-  -  -) in
water. The inset shows the d–d band of complexes 1–3.
Table 2
Selected crystallographic data for 4  H2O and 6
4  H2O 6
Formula C16H24CuN4O7 C20H22ClCuN5O7
Crystal size (mm) 0.26  0.18  0.12 0.65  0.30  0.20
Formula weight (g M1) 447.93 543.42
Crystal system monoclinic triclinic
Space group (no.) P21 (no. 4) P1 (no. 1)
a (A˚) 11.559(4) 8.2524(19)
b (A˚) 6.659(2) 11.940(3)
c (A˚) 13.226(5) 13.440(3)
a () 90.0 109.257(4)
b () 92.777(6) 101.000(4)
c () 90.0 106.193(4)
V (A˚3) 1016.8(6) 1140.7(5)
Z 2 2
T (K) 293(2) 293(2)
Dcalc (g cm
3) 1.463 1.582
k (A˚) (Mo Ka) 0.71073 0.71073
Absorption coeﬃcient (cm1) 11.18 11.27
Data/restraints/parameters 3885/1/253 8546/3/613
Goodness-of-ﬁt on F2 1.130 1.025
R (Fo)
a [I > 2r(I)] (R [all data]) 0.0404 (0.0448) 0.0547 (0.0882)
wR (Fo)
b [I > 2r(I)] (wR [all
data])
0.1138 (0.1166) 0.1198 (0.1378)
Largest diﬀerence in peak and
hole (e A˚3)
0.679 and 0.266 0.485 and 0.273
w = 1/[r2(F2o) + (AP)
2 + (BP)] A = 0.0595;
B = 0.1680
A = 0.0640;
B = 0.0000
a R =
PkFo|  |Fck/
P
|Fo|.
b wR = {
P
[w(F2o  F2c)2]/
P
[w(Fo)
2]}1/2; w = [r2(Fo)
2 + (AP)2 + BP]1,
P = (F2o + 2F
2
c)/3.
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water in the elongated axial position. Complexes 4 and 6
crystallize in the non-centrosymmetric P21 (monoclinic)
andP1 (triclinic) space groups, having one and two indepen-
dent molecules in the crystallographic asymmetric unit
respectively. The copper(II) ion is coordinated in a distorted
square-pyramidal (4 + 1) coordination geometry through
the carboxylate oxygen atom O(1) and the amino nitrogen
atom N(3) of L-isoleucine and two N-atoms of 2,20-bipyri-
dine/dpq and a weakly bound apical water molecule
(average trigonal distortion parameter, s (4  H2O) =
0.268; sav (6) = 0.087) [39]. Both the structures resemble
the corresponding known structure of [Cu(L-leu/L-ile)
(phen)(H2O)](NO3) [27]. The conﬁguration at the isoleucine
chiral a-carbon is S in both complexes. The copper atom is
displaced by 0.15 and 0.19 A˚ from the mean plane
through its basal atoms in the direction towards the apical
water molecule for complexes 4 and 6, respectively.Both the bpy (4) and dpq (6) structures show extensive
intermolecular non-covalent interactions. While one
hydrogen atom of the axial water ligand is hydrogen-
bonded to the carboxylate oxygen atom belonging to the
neighbouring molecule (distances: 2.678 and 2.819 A˚), the
other hydrogen atom is H-bonded with the oxygen atom
of the lattice NO3
=ClO4
 anion (distances: 2.776 and
2.851 A˚). The unit cell packing diagrams and intermolecu-
lar hydrogen bonding interactions present in 4  H2O and 6
are shown in Figs. S1–S4 (see supporting information).
Fig. 2. ORTEP diagram of complex 4 showing 50% probability thermal
ellipsoids with the atom labelling scheme for the metal and heteroatoms.
Fig. 3. ORTEP diagram of two independent molecules of complex 6
showing 30% probability thermal ellipsoids with the atom labelling scheme
for the metal and heteroatoms.
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The binding of complexes 1–6 to calf thymus (CT) DNA
has been studied by electronic absorption spectral tech-
niques. The interaction of complex 5 with DNA had been
reported earlier [27d]. We have studied this complex for
comparison with the other analogous complexes here.
The absorption spectral traces of complex 3 with increasing
concentration of CT DNA are shown in Fig. 4. We have
observed a minor bathochromic shift of 3 nm along with
signiﬁcant hypochromicity for the phen and dpq com-
plexes. The intrinsic DNA binding constants (Kb) of the
complexes to CT DNA are obtained by monitoring thechange of the absorption intensity of the spectral bands
with increasing concentration of CT DNA, keeping the
complex concentration constant. The bpy complexes show
weak binding to the DNA due to less extended planarity
compared to phen or dpq, which is consistent with the
observed trend in hypochromism. The Kb values for com-
plexes 2 and 3 are 5.1  103 and 1.05  104 M1, respec-
tively. The higher binding propensity of the phen and
dpq complexes in comparison to their bpy analogues could
be due to the presence of extended planar aromatic rings
facilitating non-covalent interactions with the DNA mole-
cule. Earlier studies on bis-phen copper complex have
shown that this complex binds to DNA either by partial
intercalation or by binding of one phen ligand to the minor
groove while the other phen making favourable contacts
within the groove [40–43]. The nature of binding of the
phen complex is proposed to be similar as observed for
the bis-phen species.
The emission spectral method is used to study the rela-
tive binding of the complexes to calf thymus-DNA. The
emission intensity of ethidium bromide (EB) is used as a
spectral probe as EB shows no apparent emission intensity
in buﬀer solution because of solvent quenching and shows
an enhancement of the emission intensity when intercala-
tively bound to DNA [44]. The binding of the complexes
to DNA decreases the emission intensity of EB. The rela-
tive binding propensity of the complexes to DNA is mea-
sured from the extent of reduction of the emission
intensity (Fig. 5, Table 1). The reduction of the emission
intensity of EB on increasing the complex concentration
could be caused due to displacement of the DNA bound
EB by the ternary copper(II) complexes.
The denaturation of DNA from double-strand to single
strand results in absorption hyperchromism at 260 nm. The
binding of metal complexes to the double-stranded DNA
usually stabilizes the duplex structure to some extent,
depending on the strength of the interaction with the
nucleic acid [45]. The binding should lead to an increase
in the melting temperature (Tm) of DNA as compared to
DNA itself. The binding of the phen and dpq complexes
results in a moderate increase (2 C) in the melting tem-
peratures (DTm) of CT-DNA suggesting primarily an elec-
trostatic and/or groove binding nature of the complexes
(Table 1, Fig. 6a).
To investigate further the binding modes of the com-
plexes viscosity measurements on solutions of calf thymus
DNA incubated with the complexes were carried out.
Because the viscosity of a DNA solution is sensitive to
the addition of organic drugs and metal complexes bound
by intercalation, we examined the eﬀect on the speciﬁc rel-
ative viscosity of DNA upon addition of complexes. The
relative speciﬁc viscosity (g/g0), (g and g0 are the speciﬁc
viscosities of DNA in the presence and absence of a com-
plex, respectively) of DNA reﬂects the increase in contour
length associated with the separation of DNA base pairs
caused by intercalation. The relative viscosity of DNA
and contour length follows the equation: (g/g0) = (L/L0)
1/3,
Table 3
Selected bond distances (A˚) and angles () for [Cu(L-ile)(bpy)(H2O)](NO3)  H2O (4  H2O) and for the two molecules of [Cu(L-ile)(dpq)(H2O)](ClO4) (6)
4  H2O 6
Molecule A Molecule B
Cu(1)–N(1) 1.991(3) 1.997(7) Cu(2)–N(6) 2.023(7)
Cu(1)–N(2) 2.014(3) 2.013(7) Cu(2)–N(7) 2.014(6)
Cu(1)–N(3) 1.972(3 2.008(7) Cu(2)–N(8) 1.978(7)
Cu(1)–O(1) 1.930(3) 1.953(6) Cu(2)–O(4) 1.894(6)
Cu(1)–O(3) 2.297(3) 2.281(6) Cu(2)–O(6) 2.294(7)
N(1)–Cu(1)–N(2) 81.11(13) 81.8(3) N(6)–Cu(2)–N(7) 82.3(3)
N(1)–Cu(1)–N(3) 179.24(13) 169.5(3) N(6)–Cu(2)–N(8) 163.0(3)
N(1)–Cu(1)–O(1) 95.09(12) 92.8(3) N(6)–Cu(2)–O(4) 94.3(3)
N(1)–Cu(1)–O(3) 90.22(13) 95.0(3) N(6)–Cu(2)–O(6) 99.2(3)
N(2)–Cu(1)–N(3) 99.59(12) 100.2(3) N(7)–Cu(2)–N(8) 97.6(3)
N(2)–Cu(1)–O(1) 163.10(15) 170.1(3) N(7)–Cu(2)–O(4) 172.9(3)
N(2)–Cu(1)–O(3) 97.78(14) 96.2(3) N(7)–Cu(2)–O(6) 91.7(3)
N(3)–Cu(1)–O(1) 84.15(12) 83.7(3) N(8)–Cu(2)–O(4) 83.9(3)
N(3)–Cu(1)–O(3) 90.00(14) 94.9(3) N(8)–Cu(2)–O(6) 97.9(3)
O(1)–Cu(1)–O(3) 98.69(12) 92.5(3) O(4)–Cu(2)–O(6) 95.0(3)
Fig. 4. (a) Absorption spectral traces on addition of CT DNA to a solution of 3 (shown by arrow). (b) Plot of [DNA]/(ea  ef) vs. [DNA] for the
absorption titration of CT-DNA with complex 3.
Fig. 5. Emission spectral changes on addition of [Cu(L-ile)(dpq)(H2O)]
(ClO4) (6) to CT-DNA bound to ethidium bromide (shown by arrow).
Inset: Eﬀect of addition of [Cu(L-ile)(B)(H2O)](X) [B = bpy (4, N); phen
(5, d); dpq (6, j)] to the emission intensity CT DNA-bound ethidium
bromide in a 5 mM Tris–HCl/5 mM NaCl buﬀer (pH 7.2) at 25 C.
R. Rao et al. / Polyhedron 27 (2008) 1343–1352 1349where L and L0 are the contour length of DNA in the pres-
ence and absence of complex respectively [37]. A classical
intercalator such as EtBr could cause a signiﬁcant increase
in the viscosity of DNA solutions, in contrast, a partial
and/or non-classical intercalation of the ligand could bend
or kink DNA resulting in a decrease in its eﬀective length
with a concomitant increase in its viscosity [46,47]. The
plots of relative viscosities with R = [Cu]/[DNA] are shown
in Fig. 6(b). The change in relative viscosity for the dpq
complexes are more than that for the phen or bpy ana-
logues suggesting greater DNA binding propensity of the
dpq complexes in comparison to the phen or bpy ana-
logues, but this change is less compared to that of potential
classical intercalators, e.g. ethidium bromide. This is con-
sistent with the observed trend shown by other optical
methods and suggests primarily an electrostatic and/or
groove binding nature of the complex.
3.4. DNA cleavage studies
The oxidative DNA cleavage activity of the complexes in
the presence of the reducing agent 3-mercaptopropionic acid
(MPA, 5 mM) was studied by agarose gel electrophoresis
Fig. 6. (a) Eﬀect of addition of complexes 3 (d) and (6) (N) (50 lM) on the melting temperature of CT- DNA (j) (200 lM) in 5 mM Phosphate buﬀer
(pH 6.85) with a ramp rate of 0.5 C/min. (b) Change in relative speciﬁc viscosity of CT-DNA (150 lM) with addition complexes 2 (d) and 3 (N) in 5 mM
Tris–Cl buﬀer medium at 37 ± 0.1 C.
Fig. 7. Gel electrophoresis diagram showing the cleavage of SC pUC19 DNA (0.2 lg, 30 lM) by complexes 1–6 (30 lM) in 50 mM Tris–HCl/50 mM
NaCl buﬀer (pH 7.2) in the presence of MPA (5 mM): Lane 1, DNA +MPA; Lane 2, DNA + L-leu (30 lM) +MPA; Lane 3, DNA + L-ile
(30 lM) +MPA; Lane 4, DNA + 2; Lane 5, DNA + 5 +MPA; Lane 6, DNA + 1 +MPA; Lane 7, DNA + 2 +MPA; Lane 8, DNA + 3 +MPA; Lane
9, DNA + 4 +MPA; Lane 10, DNA + 5; Lane 11, DNA + 6 +MPA; Lane 12, DNA + distamycin-A (100 lM) + 2 +MPA; Lane 13, DNA + dista-
mycin-A (100 lM) + 6 +MPA.
Table 4
Selected cleavage data of SC pUC19 (0.2 lg, 30 lM NP) by complexes 1–
6a
Sl.
no
Reaction condition [Complex]/
lM
%
SC
%
NC
1 DNA +MPA 97 3
2 DNA + L-leucine
(30 lM) +MPA
95 5
3 DNA + L-isoleucine
(30 lM) +MPA
96 4
4 DNA + 2 30 92 8
5 DNA + 5 30 94 6
6 DNA + 1 +MPA 30 86 14
7 DNA + 2 +MPA 30 24 76
8 DNA + 3 +MPA 30 10 90b
9 DNA + 4 +MPA 30 88 12
10 DNA + 5 +MPA 30 28 72
11 DNA + 6 +MPA 30 11 89b
12 DNA + distamycin-
Ac + 2 +MPA
30 74 26
13 DNA + distamycin-
A + 6 +MPA
30 70 30
14 DNA + DMSOd + 2 +MPA 30 90 10
15 DNA + catalasee + 2 +MPA 30 84 16
16 DNA + KIf + 2 +MPA 30 86 14
17 DNA + mannitolg + 2 +MPA 30 88 12
18 DNA + SODh + 2 +MPA 30 30 70
a SC and NC are supercoiled and nicked circular forms of DNA.
[MPA] = 5 mM.
b Including 15–20% linear form.
c 100 lM.
d 4 lL.
e 4 units.
f 1 mM.
g 1 mM.
h 4 units.
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30 lM NP) in 50 mM Tris–HCl/50 mM NaCl buﬀer (pH,
7.2) and the copper(II) complexes (Fig. 7). Selected DNA
cleavage data are given in Table 4. The phen and dpq com-
plexes show signiﬁcant ‘‘chemical nuclease” activity. 30 lM
of complexes 3 and 6 show almost complete conversion of
the SC (form I) to its nicked circular form (NC, form II)
of DNA. Control experiments using only MPA or the ter-
nary complexes alone do not show any apparent conversion
of SC to its nicked-circular (NC) form. The DNA cleavage
activity order for the complexes follows the relative binding
propensities of the complexes to DNA. The bpy complexes
are cleavage inactive due to their poor binding ability to ds-
DNA. This may be attributed to ROS forms which may not
be able to reach the SC-DNA by diﬀusion and consequently
are quenched by solvent molecules. To determine the
groove binding preference of the complexes, control exper-
iments have been carried out in the presence of the minor
groove binder distamycin-A [48]. Inhibition of cleavage in
the presence of distamycin-A for both the phen and dpq
complexes suggest their minor groove binding nature.
Mechanistic aspects of the chemical nuclease reactions
were investigated using various control experiments
(Fig. 8). The addition of hydroxyl radical scavengers, [49]
like DMSO, catalase and KI, shows signiﬁcant inhibition
of the DNA cleavage activity of the complexes, indicating
the possibility of the involvement of the hydroxyl radical
and/or a ‘‘copper-oxo” intermediate as the reactive species.
Addition of superoxide dismutase (SOD) does not show
any apparent eﬀect on the DNA cleavage activity, suggest-
ing the non-involvement of O2
 in the cleavage reaction
Fig. 8. Cleavage of SC pUC19 DNA (30 lM) by [Cu(L-leu)(phen)
(H2O)](NO3) (2) in the presence of MPA (5 mM) with various additives
in Tris buﬀer (pH 7.2) medium. The additive concentrations/quantity are:
DMSO (4 lL), catalase (4 U), KI (1 mM), mannitol (1 mM), SOD (4 U).
Scheme 2. Proposed mechanistic pathway for the chemical nuclease
activity of the complexes in Tris–buﬀer medium.
R. Rao et al. / Polyhedron 27 (2008) 1343–1352 1351[50]. The pathways involved in the DNA cleavage reactions
are believed to be analogous to those proposed by Sigman
and coworkers for the chemical nuclease activity of
bis(phen)copper species (Scheme 2) [1,43,44].
4. Conclusions
Ternary redox active copper(II) complexes having
N,O-donor a-amino acid L-leucine or L-isoleucine and
N,N-donor heterocyclic bases have been prepared and
characterized. The copper(II) complexes with planar phe-
nanthroline bases, with a CuN3O2 coordination geometry,
show eﬃcient DNA binding ability. The phen and dpq
complexes were shown to be DNA minor groove binders.
The study also conﬁrms that the binding ability of the com-
plexes is an important precondition to show eﬃcient DNA
cleavage activity. Eﬃcient chemical nuclease activity is
observed for the redox active phen and dpq complexes
under physiological reaction conditions via a mechanistic
pathway involving formation of hydroxyl radicals in the
presence of the reducing agent MPA.
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